• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

AXA Framlington Health Z INC

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider AXA Investment Managers UK Limited
Fund Summary The aim of the Fund is to generate capital growth through investment in healthcare and medical services and product companies worldwide.
SEDOL code BRJZVQ7
ISIN GB00BRJZVQ71
Fund code FMHZI
Managers Dani Saurymper
Manager Tenure 3 years
Morningstar Category Sector Equity Healthcare
IMA Sector Specialist
Fund Size £480 million
Fund Type OEIC
Management Style Active
Total Expense Ratio (TER) 0.82%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £1.337
Buy Price £1.337
Price Change +0.2249%
Price Date 14th June 2019
Yield 0.23%
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 24th April 1987
Fund Status OPEN
Dani Saurymper joined AXA IM in April 2015 as Fund Manager for the AXA Framlington Health Fund. He joined from Barclays Capital where he was a senior equity research analyst covering European healthcare.

3-year Mean Monthly Return: 0.753%

Annual Returns 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Fund Performance +17.73% -8.95% +25.39% -9.62% +44.48% +15.23% +25.73% +8.96% +4.44% +38.45%
Benchmark Performance
(Sector Equity Healthcare)
+18.61% -4.12% +24.93% -10.46% +40.27%
Time Period Cumulative Benchmark Performance
(Sector Equity Healthcare)
Fund Compared to Benchmark
1 day 0.22% -0.15% +0.37%
1 week 1.75% +1.50% +0.25%
1 month 4.78% +3.69% +1.09%
3 months 0.00% +1.52% Currently unavailable
6 months 0.38% +1.20% -0.83%
1 year 6.01% +6.07% -0.06%
3 years 30.05% +35.37% -5.31%
5 years 76.98% +72.45% +4.53%
10 years 312.23% +284.71% +27.52%
YTD 9.95% +8.18% +1.77%
Since inception 4388.13% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Merck & Co Inc USA 6.12%
UnitedHealth Group Inc USA 5.21%
GlaxoSmithKline PLC GBR 4.37%
Thermo Fisher Scientific Inc USA 4.15%
Anthem Inc USA 3.92%
Medtronic PLC USA 3.66%
Takeda Pharmaceutical Co Ltd JPN 3.36%
Alexion Pharmaceuticals Inc USA 3.22%
Allergan PLC USA 3.10%
Eli Lilly and Co USA 3.03%
Dividend Date Per share amount Reinvestment Price
1st November 2018 0.0029 £1.3090
1st November 2017 0.0045 £1.1740
1st November 2016 0.0041 £1.1330
2nd November 2015 0.0023 £1.0000